Email this article 
Altered strategy in the treatment of patients with recurrent ovarian cancer. According to the proceedings of the 5th International Conference on Gynecologic Oncology hosted by the MD Anderson Cancer Center (Madrid, Spain, 24–26 February 2016)
- Authors: Kedrova A.G.1,2,3,4
-
Affiliations:
- Department of Oncology, Federal Research and Clinical Center for Specialized Medical Cares and Medical Technologies, Federal Biomedical Agency of Russia
- 28 Orekhovyy Boulevard, Moscow, 115682, Russia
- Department of Obstetrics and Gynecology, Institute for Advanced Training, Federal Biomedical Agency of Russia
- 91 Volokolamskoe Shosse, Moscow, 125371, Russia
- Issue: Vol 12, No 1 (2016)
- Pages: 68-72
- Section: ГИНЕКОЛОГИЯ. ОБЗОР
- Published: 06.06.2016
- URL: https://ojrs.abvpress.ru/ojrs/article/view/479
- DOI: https://doi.org/10.17650/1994-4098-2016-12-1-68-72
- ID: 479
Cite item
Full Text
Abstract
The paper highlights main areas in the development of European oncology care to patients with malignant ovarian neoplasms. It discusses the major issues considered at the 5th Annual Meeting of Oncologists on Arrangement of Anticancer Therapy into the Era of Personalized Therapy hosted by the MD Anderson Cancer Center.
Keywords
About the authors
A. G. Kedrova
Department of Oncology, Federal Research and Clinical Center for Specialized Medical Cares and Medical Technologies, Federal Biomedical Agency of Russia; 28 Orekhovyy Boulevard, Moscow, 115682, Russia;Department of Obstetrics and Gynecology, Institute for Advanced Training, Federal Biomedical Agency of Russia; 91 Volokolamskoe Shosse, Moscow, 125371, Russia
Author for correspondence.
Email: kedrova.anna@gmail.com
Russian Federation
References
Supplementary files
